Hepatocellular Carcinogenesis Imaging Techniques

Imaging of hepatocellular carcinogenesis encompasses a spectrum of modalities designed to detect, characterise and monitor the progression of pre-malignant and malignant liver lesions. Conventional methods such as ultrasound and computed tomography (CT) serve as first-line tools for surveillance, relying on lesion size, morphology and vascular patterns. Magnetic resonance imaging (MRI) extends this capability through dynamic contrast enhancement and functional sequences, including diffusion-weighted imaging and hepatocyte-specific contrast agents, which highlight alterations in cellular density, perfusion and hepatobiliary uptake. Advanced approaches now integrate elastography to assess tissue stiffness, perfusion imaging for real-time blood flow analysis and radiomic algorithms to extract quantitative features of lesion heterogeneity. Contrast-enhanced ultrasound further enriches vascular characterisation by using microbubble agents to visualise arterial hypervascularity and washout kinetics without ionising radiation. Together, these developments aim to distinguish regenerative nodules, dysplastic lesions and early hepatocellular carcinoma with greater precision, enabling prompt intervention and improved patient outcomes across diverse clinical settings.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies have highlighted the power of multi-parametric imaging and computational analysis in refining early detection of precancerous liver lesions. A 2023 investigation combined CT arterial portography, ultrasound elastography and laboratory biomarkers to enhance the characterisation of dysplastic nodules in cirrhotic livers, achieving greater diagnostic confidence in distinguishing high-risk lesions. In 2020, researchers applied texture analysis to T2-weighted MRI scans for differentiation of small (≤3 cm) hepatocellular carcinomas from dysplastic nodules, reporting markedly improved sensitivity and specificity compared with conventional qualitative assessment. An additional study of gadoxetic acid-enhanced MRI demonstrated that inclusion of the hepatobiliary phase significantly increased accuracy for lesions ≤2 cm, offering clearer delineation of well-differentiated tumours and informing treatment planning. Collectively, these works underscore a shift towards quantitative, functional and hepatocyte-targeted imaging metrics to guide early intervention in hepatocarcinogenesis.

Hepatocellular Carcinogenesis Imaging Techniques publication trend

The graph below shows the total number of articles in hepatocellular carcinogenesis imaging techniques across all publications each year (not limited to Nature Index journals).

Technical terms

Dysplastic nodule: A pre-malignant liver lesion exhibiting cellular atypia without evidence of invasive carcinoma.

Contrast-enhanced ultrasound (CEUS): An ultrasound technique employing microbubble agents to visualise lesion vascularity and perfusion patterns.

Gadoxetic acid: A hepatocyte-specific MRI contrast agent enabling enhanced visualisation of liver parenchyma in the hepatobiliary phase.

Diffusion-weighted imaging (DWI): An MRI sequence that measures the random motion of water molecules to assess tissue cellularity and integrity.

Texture analysis: A radiomic method that extracts quantitative descriptors of image heterogeneity to characterise tissue architecture.

References

1. Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis. Diagnostics (2023).
2. Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI. BMC Medical Imaging (2016).
3. Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging. Frontiers in Oncology (2020).